| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Derek M. Yellon | Q33528795 |
| Derek Hausenloy | Q42409890 | ||
| P2860 | cites work | A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter | Q24306850 |
| Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning | Q28187266 | ||
| Myocardial reperfusion: a double-edged sword? | Q28236054 | ||
| Low-pressure reperfusion alters mitochondrial permeability transition | Q28302758 | ||
| Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury | Q33195698 | ||
| Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial | Q33535020 | ||
| Cyclosporine A at reperfusion reduces infarct size in pigs | Q33791098 | ||
| Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model | Q34004756 | ||
| Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardi | Q74269709 | ||
| Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction | Q74302899 | ||
| A fresh look at reperfusion injury | Q77111306 | ||
| Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction | Q77298898 | ||
| Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats | Q77745998 | ||
| Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning | Q79511809 | ||
| Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging | Q79955258 | ||
| The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis | Q80049559 | ||
| Postconditioning: old wine in a new bottle? | Q80508002 | ||
| The ST-segment-elevation myocardial infarction chain of survival | Q80558055 | ||
| Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention | Q80698978 | ||
| Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging | Q81406260 | ||
| Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection | Q82471465 | ||
| Postconditioning for protection of the infarcting heart | Q82531706 | ||
| Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation | Q83022905 | ||
| Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction | Q83610161 | ||
| Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial | Q83655925 | ||
| Delayed postconditioning in the mouse heart in vivo | Q84851503 | ||
| Molecular imaging: T2-weighted CMR of the area at risk--a risky business? | Q85074755 | ||
| Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction | Q71571199 | ||
| Blood Supply of the Myocardium after Temporary Coronary Occlusion | Q72783959 | ||
| The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion | Q73256108 | ||
| Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion | Q73265301 | ||
| Transient limb ischemia induces remote ischemic preconditioning in vivo. | Q34162086 | ||
| Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial | Q34204296 | ||
| Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion | Q34204642 | ||
| Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations | Q34247485 | ||
| Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion | Q34305822 | ||
| Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans | Q34534066 | ||
| Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects | Q34547174 | ||
| Direct measurement of free radical generation following reperfusion of ischemic myocardium | Q34602572 | ||
| Myocardial reperfusion injury. | Q34687124 | ||
| The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance | Q34770962 | ||
| Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. | Q34935546 | ||
| Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury | Q35225599 | ||
| Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury | Q35666905 | ||
| Cardiac protection during acute myocardial infarction: where do we stand in 2004? | Q35840326 | ||
| Myocardial protection at a crossroads: the need for translation into clinical therapy | Q35844649 | ||
| No-reflow phenomenon and prognosis in patients with acute myocardial infarction | Q36577567 | ||
| Imaging microvascular obstruction and its clinical significance following acute myocardial infarction | Q36666471 | ||
| New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop | Q37007953 | ||
| Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. | Q37019662 | ||
| Remote ischaemic preconditioning: underlying mechanisms and clinical application. | Q37154560 | ||
| Coronary microembolization: from bedside to bench and back to bedside | Q37626321 | ||
| Cardiac preconditioning for ischaemia: lost in translation. | Q37675573 | ||
| Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology | Q37744271 | ||
| MRI in acute myocardial infarction | Q37812993 | ||
| Mitochondria-targeted small molecule therapeutics and probes | Q37851996 | ||
| Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. | Q38376053 | ||
| Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction | Q38376826 | ||
| Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial | Q38400764 | ||
| Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial | Q38470631 | ||
| Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia | Q38473330 | ||
| Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial | Q38473353 | ||
| STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication | Q38480556 | ||
| Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction | Q38498683 | ||
| Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial | Q38500791 | ||
| A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction | Q38500796 | ||
| Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction | Q39868576 | ||
| Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study | Q40280772 | ||
| The pH paradox in ischemia-reperfusion injury to cardiac myocytes. | Q41111234 | ||
| Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction | Q41118717 | ||
| Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion | Q41977320 | ||
| Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes | Q42449618 | ||
| Effect of temperature on myocardial infarction in swine | Q42646368 | ||
| A single dose of erythropoietin in ST-elevation myocardial infarction | Q42923034 | ||
| Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. | Q43124896 | ||
| Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction | Q43124905 | ||
| Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action | Q43175053 | ||
| Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. | Q43298149 | ||
| Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial | Q43777913 | ||
| Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? | Q44088292 | ||
| Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial | Q45238837 | ||
| Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury | Q45255900 | ||
| Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart | Q45866840 | ||
| Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. | Q45971753 | ||
| Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts | Q46060146 | ||
| Effect of cyclosporine on reperfusion injury in acute myocardial infarction | Q46453592 | ||
| A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). | Q46528602 | ||
| Mitochondrial permeability transition pore as a target for cardioprotection in the human heart | Q46551313 | ||
| Postconditioning the human heart | Q46722557 | ||
| Long-term benefit of postconditioning | Q46758924 | ||
| Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials | Q46928598 | ||
| Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging | Q46989196 | ||
| Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation | Q47300587 | ||
| Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit | Q47301701 | ||
| Short-term low dose intracoronary diltiazem administered at the onset of reperfusion reduces myocardial infarct size | Q47313235 | ||
| The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs | Q47325541 | ||
| Intracoronary aqueous oxygen perfusion, performed 24 h after the onset of postinfarction reperfusion, experimentally reduces infarct size and improves left ventricular function | Q47339435 | ||
| Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention | Q47340489 | ||
| Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction? | Q47355940 | ||
| Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention | Q47360567 | ||
| Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy | Q47957724 | ||
| Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest | Q48356691 | ||
| Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial | Q48572279 | ||
| Remote Ischemic Conditioning in Patients With Myocardial Infarction Treated With Primary Angioplasty: Impact on Left Ventricular Function Assessed by Comprehensive Echocardiography and Gated Single-Photon Emission CT. | Q50695540 | ||
| Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. | Q51228456 | ||
| Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. | Q51619864 | ||
| Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. | Q51808889 | ||
| Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction | Q58447894 | ||
| Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a K ATP Channel–Dependent Mechanism | Q59401736 | ||
| Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release | Q68669043 | ||
| Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart | Q69018468 | ||
| Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis | Q70061378 | ||
| Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction | Q70866648 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 92-100 | |
| P577 | publication date | 2013-01-02 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Myocardial ischemia-reperfusion injury: a neglected therapeutic target | |
| P478 | volume | 123 |
| Q55031839 | 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone Ameliorates Myocardial Ischemia/Reperfusion Injury in Rat by Inhibiting Apoptosis and Autophagy Via the PI3K-Akt Signal Pathway. |
| Q47332114 | 2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice |
| Q36852542 | A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion |
| Q64889222 | A Meta-Analysis of Resveratrol Protects against Myocardial Ischemia/Reperfusion Injury: Evidence from Small Animal Studies and Insight into Molecular Mechanisms. |
| Q89121181 | A Retinoic Acid β2-Receptor Agonist Exerts Cardioprotective Effects |
| Q36274955 | A Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms. |
| Q48245528 | A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction |
| Q39172264 | A growing role for the Hippo signaling pathway in the heart |
| Q35155485 | A small molecule activator of AKT does not reduce ischemic injury of the rat heart. |
| Q38828022 | Acetylcholine Attenuates Hypoxia/Reoxygenation Injury by Inducing Mitophagy Through PINK1/Parkin Signal Pathway in H9c2 Cells |
| Q91332961 | Activation mechanisms and multifaceted effects of mast cells in ischemia reperfusion injury |
| Q36104970 | Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death |
| Q41320036 | Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in Rats |
| Q43127871 | Activation of SHH signaling pathway promotes vasculogenesis in post-myocardial ischemic-reperfusion injury |
| Q102319576 | Activation of the CaR-CSE/H2S pathway confers cardioprotection against ischemia-reperfusion injury |
| Q47987509 | Acute hot water immersion is protective against impaired vascular function following forearm ischemia-reperfusion in young healthy humans. |
| Q36095060 | Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison |
| Q50053966 | Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury. |
| Q90642839 | Adropin reduces hypoxia/reoxygenation-induced myocardial injury via the reperfusion injury salvage kinase pathway |
| Q42220250 | Advances in the Diagnosis of Sepsis: Hydrogen Sulfide as a Prognostic Marker of Septic Shock Severity |
| Q54976593 | Agomelatine protects against myocardial ischemia reperfusion injury by inhibiting mitochondrial permeability transition pore opening. |
| Q40352247 | Alteration of Multiple Leukocyte Gene Expression Networks is Linked with Magnetic Resonance Markers of Prognosis After Acute ST-Elevation Myocardial Infarction |
| Q92887403 | Alterations in amino acid levels and metabolite ratio of spinal cord in rat with myocardial ischemia-reperfusion injury by proton magnetic resonance spectroscopy |
| Q37578724 | Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion |
| Q54920287 | An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning. |
| Q58544725 | Analyses of changes in myocardial long non-coding RNA and mRNA profiles after severe hemorrhagic shock and resuscitation via RNA sequencing in a rat model |
| Q36846937 | Anti-Apoptotic and Pro-Survival Effect of Alpinate Oxyphyllae Fructus (AOF) in a d-Galactose-Induced Aging Heart. |
| Q52947173 | Anti-apoptotic effect of microRNA-30b in early phase of rat myocardial ischemia-reperfusion injury model. |
| Q47744781 | Anti-inflammatory Nanomedicine for Cardiovascular Disease. |
| Q89099762 | Apigenin suppresses the apoptosis of H9C2 rat cardiomyocytes subjected to myocardial ischemia‑reperfusion injury via upregulation of the PI3K/Akt pathway |
| Q55411917 | Apoptosis and Mobilization of Lymphocytes to Cardiac Tissue Is Associated with Myocardial Infarction in a Reperfused Porcine Model and Infarct Size in Post-PCI Patients. |
| Q89823704 | Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases |
| Q64233416 | Apurinic/apyrimidinic endonuclease/redox factor 1 (APE1) alleviates myocardial hypoxia-reoxygenation injury by inhibiting oxidative stress and ameliorating mitochondrial dysfunction |
| Q55384417 | Araloside C Prevents Hypoxia/Reoxygenation-Induced Endoplasmic Reticulum Stress via Increasing Heat Shock Protein 90 in H9c2 Cardiomyocytes. |
| Q50143099 | Arginase: A Multifaceted Enzyme Important in Health and Disease. |
| Q46916090 | Argon Exposure Induces Postconditioning in Myocardial Ischemia-Reperfusion |
| Q55269049 | Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in rats. |
| Q38688054 | Association between Air Temperature and Acute Myocardial Infarction Hospitalizations in Tehran, Iran: A Time-Stratified Case-Crossover. |
| Q46564801 | Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein |
| Q38837178 | Autophagy in cardiac metabolic control: Novel mechanisms for cardiovascular disorders |
| Q37224702 | Autophagy protects cardiomyocytes from the myocardial ischaemia-reperfusion injury through the clearance of CLP36. |
| Q28086932 | Autophagy, a process within reperfusion injury: an update |
| Q47355559 | BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury |
| Q64884862 | Baicalin Depresses the Sympathoexcitatory Reflex Induced by Myocardial Ischemia via the Dorsal Root Ganglia. |
| Q38732088 | Bauhinia championii Flavone Attenuates Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes by Improving Mitochondrial Dysfunction. |
| Q36274372 | Bauhinia championii flavone inhibits apoptosis and autophagy via the PI3K/Akt pathway in myocardial ischemia/reperfusion injury in rats |
| Q36405714 | Berberine Attenuates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation Response: Role of Silent Information Regulator 1. |
| Q91942023 | Berberine Protects Against Simulated Ischemia/Reperfusion Injury-Induced H9C2 Cardiomyocytes Apoptosis In Vitro and Myocardial Ischemia/Reperfusion-Induced Apoptosis In Vivo by Regulating the Mitophagy-Mediated HIF-1α/BNIP3 Pathway |
| Q64239467 | Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction |
| Q90199537 | Bioreactor-based 3D human myocardial ischemia/reperfusion in vitro model: a novel tool to unveil key paracrine factors upon acute myocardial infarction |
| Q41717395 | Bisoprolol protects myocardium cells against ischemia/reperfusion injury by attenuating unfolded protein response in rats |
| Q37644143 | Blockage of transient receptor potential vanilloid 4 alleviates myocardial ischemia/reperfusion injury in mice. |
| Q92137428 | Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7 |
| Q91970831 | C-Phycocyanin Ameliorates Mitochondrial Fission and Fusion Dynamics in Ischemic Cardiomyocyte Damage |
| Q90441319 | C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond |
| Q91891449 | C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature |
| Q37187476 | CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in mice |
| Q37172088 | CD38 Deficiency Protects the Heart from Ischemia/Reperfusion Injury through Activating SIRT1/FOXOs-Mediated Antioxidative Stress Pathway. |
| Q53615185 | CMX-2043 Efficacy in a Rat Model of Cardiac Ischemia-Reperfusion Injury. |
| Q35922588 | CTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury |
| Q35995068 | CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury |
| Q46615618 | CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. |
| Q90447428 | Capsaicin Alleviates the Deteriorative Mitochondrial Function by Upregulating 14-3-3η in Anoxic or Anoxic/Reoxygenated Cardiomyocytes |
| Q35932474 | Captopril Pretreatment Produces an Additive Cardioprotection to Isoflurane Preconditioning in Attenuating Myocardial Ischemia Reperfusion Injury in Rabbits and in Humans. |
| Q39416228 | Cardiac Fibroblast GRK2 Deletion Enhances Contractility and Remodeling Following Ischemia/Reperfusion Injury |
| Q47664602 | Cardiac Ischemia/Reperfusion Injury: The Beneficial Effects of Exercise. |
| Q64081787 | Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury |
| Q38412226 | Cardiac Myocyte-specific Knock-out of Calcium-independent Phospholipase A2γ (iPLA2γ) Decreases Oxidized Fatty Acids during Ischemia/Reperfusion and Reduces Infarct Size |
| Q41102519 | Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion |
| Q89799889 | Cardiac complex II activity is enhanced by fat and mediates greater mitochondrial oxygen consumption following hypoxic re-oxygenation |
| Q35156767 | Cardiac function in a long-term follow-up study of moderate and severe porcine model of chronic myocardial infarction |
| Q57472323 | Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction |
| Q35186568 | Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury |
| Q35641335 | Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules |
| Q38686480 | Cardiomyocyte Ca2+ dynamics: clinical perspectives |
| Q38124357 | Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives |
| Q35661834 | Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. |
| Q38546856 | Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation |
| Q42265306 | Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus |
| Q35881667 | Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury |
| Q36980459 | Cardioprotective Effect of Electroacupuncture Pretreatment on Myocardial Ischemia/Reperfusion Injury via Antiapoptotic Signaling |
| Q35123604 | Cardioprotective activity of iron oxide nanoparticles |
| Q64279302 | Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury |
| Q92845117 | Cardioprotective effects of idebenone do not involve ROS scavenging: Evidence for mitochondrial complex I bypass in ischemia/reperfusion injury |
| Q46614298 | Cardioprotective effects of low-level carotid baroreceptor stimulation against myocardial ischemia-reperfusion injury in canine model |
| Q60919993 | Cardiovascular drugs attenuated myocardial resistance against ischaemia-induced and reperfusion-induced injury in a rat model of repetitive occlusion |
| Q42438941 | Cardiovascular science: opportunities for translating research into improved care |
| Q92943132 | Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X7R/NLRP3 inflammasome |
| Q64259723 | Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury |
| Q50351165 | Characterization of extracellular vesicles derived from cardiac cells in an in vitro model of preconditioning. |
| Q99418438 | CircPAN3 ameliorates myocardial ischaemia/reperfusion injury by targeting miR-421/Pink1 axis-mediated autophagy suppression |
| Q89964178 | Clemastine Fumarate Protects Against Myocardial Ischemia Reperfusion Injury by Activating the TLR4/PI3K/Akt Signaling Pathway |
| Q64967638 | Clinical associations of microvascular obstruction and intramyocardial hemorrhage on cardiovascular magnetic resonance in patients with acute ST segment elevation myocardial infarction (STEMI): An observational cohort study. |
| Q36091469 | Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials |
| Q47109914 | Clinical observation of ulinastatin combined with CRRT in the treatment of early cardiopulmonary resuscitation |
| Q91596534 | Combination of the ginsenosides Rb3 and Rb2 exerts protective effects against myocardial ischemia reperfusion injury in rats |
| Q47136260 | Combined postconditioning with ischemia and cyclosporine-A restore oxidative stress and histopathological changes in reperfusion injury of diabetic myocardium |
| Q89160957 | Comparative effects of calcium and potassium channel modulators on ischemia/reperfusion injury in the isolated rat heart |
| Q41458720 | Comparative metabonomics of Wenxin Keli and Verapamil reveals differential roles of gluconeogenesis and fatty acid β-oxidation in myocardial injury protection. |
| Q47653397 | Complement Receptor C5aR1 Plays an Evolutionarily Conserved Role in Successful Cardiac Regeneration. |
| Q30669527 | Concentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia/reperfusion |
| Q37427908 | Controlled Reperfusion Strategies Improve Cardiac Hemodynamic Recovery after Warm Global Ischemia in an Isolated, Working Rat Heart Model of Donation after Circulatory Death (DCD). |
| Q51542881 | Coronary arterial BK channel dysfunction exacerbates ischemia/reperfusion-induced myocardial injury in diabetic mice. |
| Q37344982 | Cox-2 Inhibition Protects against Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Akt-Dependent Enhancement of iNOS Expression |
| Q92410089 | Cox-2 Negatively Affects the Protective Role of Propofol against Hypoxia/Reoxygenation Induced Cardiomyocytes Apoptosis through Suppressing Akt Signaling |
| Q64279791 | Critical role of Lin28-TNFR2 signalling in cardiac stem cell activation and differentiation |
| Q89984760 | Critical roles of microRNA-141-3p and CHD8 in hypoxia/reoxygenation-induced cardiomyocyte apoptosis |
| Q93140380 | Curcumin attenuates hypoxia/reoxygenation‑induced cardiomyocyte injury by downregulating Notch signaling |
| Q38256651 | Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspective. |
| Q60960115 | Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool |
| Q90596638 | Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion |
| Q30376990 | Delivery of Hydrogen Sulfide by Ultrasound Targeted Microbubble Destruction Attenuates Myocardial Ischemia-reperfusion Injury |
| Q64275820 | Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction |
| Q33846962 | Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes |
| Q34268690 | Did a classic preconditioning study provide a clue to the identity of the mitochondrial permeability transition pore? |
| Q37181412 | Disruption of TAB1/p38α interaction using a cell-permeable peptide limits myocardial ischemia/reperfusion injury |
| Q55303250 | Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes. |
| Q41248810 | Distribution of Systemically Administered Nanoparticles Reveals a Size-Dependent Effect Immediately following Cardiac Ischaemia-Reperfusion Injury |
| Q92920713 | Diversity and Composition of Rumen Bacteria, Fungi, and Protozoa in Goats and Sheep Living in the Same High-Altitude Pasture |
| Q47742123 | Downregulation of P2Y12 in the superior cervical ganglia alleviates abnormal sympathetic activity after myocardial ischemia. |
| Q36865307 | Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury |
| Q92572385 | E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis |
| Q61448991 | Ebselen protects rat hearts against myocardial ischemia-reperfusion injury |
| Q89586403 | Effect of Autophagy Inhibition on the Protection of Ischemia Preconditioning against Myocardial Ischemia/Reperfusion Injury in Diabetic Rats |
| Q61445734 | Effect of High-Dose Statin Pretreatment for Myocardial Perfusion in Patients Receiving Percutaneous Coronary Intervention (PCI): A Meta-Analysis of 15 Randomized Studies |
| Q90344500 | Effect of Prostaglandin E1 Injected Into Donors in a Heterotopic Heart Transplant Model of Sprague Dawley Rats |
| Q88551555 | Effect of Sodium Thiosulfate Postconditioning on Ischemia-Reperfusion Injury Induced Mitochondrial Dysfunction in Rat Heart |
| Q92241217 | Effect of Telmisartan in the Oxidative Stress Components Induced by Ischemia Reperfusion in Rats |
| Q35215102 | Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus |
| Q42138256 | Effect of dexmedetomidine on diseased coronary vessel diameter and myocardial protection in percutaneous coronary interventional patients |
| Q91741655 | Effect of moxibustion preconditioning on autophagy-related proteins in rats with myocardial ischemia reperfusion injury |
| Q60721643 | Effect of remote ischemic postconditioning during thrombolysis in STEMI |
| Q64080872 | Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention |
| Q46712429 | Effects of endovascular cooling on infarct size in ST-segment elevation myocardial infarction: A patient-level pooled analysis from randomized trials |
| Q85456046 | Effects of ischemia and omeprazole preconditioning on functional recovery of isolated rat heart |
| Q52579444 | Effects of microRNA-292-5p on myocardial ischemia-reperfusion injury through the peroxisome proliferator-activated receptor-α/-γ signaling pathway. |
| Q97549244 | Effects of progranulin on the pathological conditions in experimental myocardial infarction model |
| Q99548968 | Effects of the Delta Opioid Receptor Agonist DADLE in a Novel Hypoxia-Reoxygenation Model on Human and Rat-Engineered Heart Tissue: A Pilot Study |
| Q38946896 | Elatoside C protects against hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes through the reduction of endoplasmic reticulum stress partially depending on STAT3 activation |
| Q54980775 | Endoplasmic Reticulum Chaperone GRP78 Protects Heart From Ischemia/Reperfusion Injury Through Akt Activation. |
| Q34795624 | Endoplasmic reticulum stress response in spontaneously hypertensive rats is affected by myocardial ischemia reperfusion injury |
| Q91815071 | Endothelial Cell Activation in an Embolic Ischemia-Reperfusion Injury Microfluidic Model |
| Q48004345 | Engineered myocardium model to study the roles of HIF-1α and HIF1A-AS1 in paracrine-only signaling under pathological level oxidative stress |
| Q41996562 | Environmental peer pressure: CD4+ T cell help in tolerance and transplantation |
| Q90310592 | Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models |
| Q90447340 | Exercise and Cardioprotection: A Natural Defense Against Lethal Myocardial Ischemia-Reperfusion Injury and Potential Guide to Cardiovascular Prophylaxis |
| Q41003426 | Exogenous NAD(+) administration significantly protects against myocardial ischemia/reperfusion injury in rat model |
| Q50085056 | Exosomes and cardioprotection - A critical analysis |
| Q64074434 | Exosomes from adipose-derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress |
| Q51440774 | Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning. |
| Q38693302 | Extracellular Ubiquitin: Role in Myocyte Apoptosis and Myocardial Remodeling |
| Q101464325 | Extracellular Vesicles Enriched with miR-150 Released by Macrophages Regulates the TP53-IGF-1 Axis to Alleviate Myocardial Infarction |
| Q90380756 | FPR1 gene silencing suppresses cardiomyocyte apoptosis and ventricular remodeling in rats with ischemia/reperfusion injury through the inhibition of MAPK signaling pathway |
| Q50958710 | Fenofibrate protects against acute myocardial I/R injury in rat by suppressing mitochondrial apoptosis as decreasing cleaved caspase-9 activation. |
| Q90248086 | Ferulic Acid Attenuates Hypoxia/Reoxygenation Injury by Suppressing Mitophagy Through the PINK1/Parkin Signaling Pathway in H9c2 Cells |
| Q54116621 | Fisetin Confers Cardioprotection against Myocardial Ischemia Reperfusion Injury by Suppressing Mitochondrial Oxidative Stress and Mitochondrial Dysfunction and Inhibiting Glycogen Synthase Kinase 3β Activity. |
| Q64240515 | Follistatin-Like 1 Attenuates Ischemia/Reperfusion Injury in Cardiomyocytes via Regulation of Autophagy |
| Q30970322 | Future directions of acute ischaemic stroke therapy |
| Q38129528 | Future treatment strategies in ST-segment elevation myocardial infarction |
| Q33604042 | G protein-coupled Receptor Kinase 2 as a Therapeutic Target for Heart Failure |
| Q57283285 | German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management |
| Q94464138 | Gerontoxanthone I and Macluraxanthone Induce Mitophagy and Attenuate Ischemia/Reperfusion Injury |
| Q32180674 | Ghrelin protected neonatal rat cardiomyocyte against hypoxia/reoxygenation injury by inhibiting apoptosis through Akt-mTOR signal |
| Q37015531 | Ginsenoside RK3 Prevents Hypoxia-Reoxygenation Induced Apoptosis in H9c2 Cardiomyocytes via AKT and MAPK Pathway |
| Q41112302 | GsMTx4-D is a cardioprotectant against myocardial infarction during ischemia and reperfusion. |
| Q47101148 | Guanxin Danshen Formulation Protects against Myocardial Ischemia Reperfusion Injury-Induced Left Ventricular Remodeling by Upregulating Estrogen Receptor β. |
| Q49917885 | Guidelines for Experimental Models of Myocardial Ischemia and Infarction |
| Q54978892 | Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis. |
| Q58557456 | Heme oxygenase-1 ameliorates hypoxia/reoxygenation via suppressing apoptosis and enhancing autophagy and cell proliferation though Sirt3 signaling pathway in H9c2 cells |
| Q54985056 | Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction. |
| Q92588566 | High cystatin C levels predict long-term mortality in patients with ST-segment elevation myocardial infarction undergoing late percutaneous coronary intervention: A retrospective study |
| Q38231258 | High density lipoproteins and ischemia reperfusion injury: the therapeutic potential of HDL to modulate cell survival pathways |
| Q64055071 | Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model |
| Q52141416 | Humanin prevents brain mitochondrial dysfunction in a cardiac ischaemia-reperfusion injury model. |
| Q35860938 | Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation |
| Q41431093 | Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling |
| Q53353117 | Icaritin Attenuates Myocardial Ischemia and Reperfusion Injury Via Anti-Inflammatory and Anti-Oxidative Stress Effects in Rats. |
| Q92814938 | Identification of lncRNA and mRNA expression profiles in rat spinal cords at various time‑points following cardiac ischemia/reperfusion |
| Q92011613 | Imbalance of ER and Mitochondria Interactions: Prelude to Cardiac Ageing and Disease? |
| Q49888772 | Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure |
| Q64054632 | Immunometabolism of Phagocytes and Relationships to Cardiac Repair |
| Q35155185 | Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study |
| Q34982390 | Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats |
| Q52655081 | Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury. |
| Q90100481 | Induced cardiac pacemaker cells survive metabolic stress owing to their low metabolic demand |
| Q98778869 | Inhibition of Rho-kinase is involved in the therapeutic effects of atorvastatin in heart ischemia/reperfusion |
| Q61449103 | Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia-reperfusion injury |
| Q90115057 | Inhibition of miR-153 ameliorates ischemia/reperfusion-induced cardiomyocytes apoptosis by regulating Nrf2/HO-1 signaling in rats |
| Q50105884 | Inhibition of nuclear factor kappa B pathway protects myocardial ischemia/reperfusion injury in rats under treatment with abnormal savda munziq |
| Q35019445 | Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart |
| Q92309402 | Inhibitor 1 of Protein Phosphatase 1 Regulates Ca2+/Calmodulin-Dependent Protein Kinase II to Alleviate Oxidative Stress in Hypoxia-Reoxygenation Injury of Cardiomyocytes |
| Q98226408 | Innate Immune Receptors, Key Actors in Cardiovascular Diseases |
| Q38438100 | Inorganic nitrite modulates miRNA signatures in acute myocardial in vivo ischemia/reperfusion |
| Q92637241 | Intermittent Hypoxia Prevents Myocardial Mitochondrial Ca2+ Overload and Cell Death during Ischemia/Reperfusion: The Role of Reactive Oxygen Species |
| Q88171503 | Intermittent hypoxia-generated ROS contributes to intracellular zinc regulation that limits ischemia/reperfusion injury in adult rat cardiomyocyte |
| Q41838401 | Intermittent pacing therapy favorably modulates infarct remodeling |
| Q89964439 | Intracellular Chloride Channels: Novel Biomarkers in Diseases |
| Q41890906 | Intracoronary hypothermia for acute myocardial infarction in the isolated beating pig heart |
| Q38268870 | Intramyocardial haemorrhage after acute myocardial infarction |
| Q100391104 | Irisin attenuates myocardial ischemia/reperfusion-induced cardiac dysfunction by regulating ER-mitochondria interaction through a mitochondrial ubiquitin ligase-dependent mechanism |
| Q28072918 | Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery |
| Q34654008 | Ischemia and reperfusion induce differential expression of calpastatin and its homologue high molecular weight calmodulin-binding protein in murine cardiomyocytes |
| Q39109413 | Ischemia/Reperfusion |
| Q37668843 | Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists |
| Q38386304 | Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial |
| Q38731870 | Keto acid metabolites of branched-chain amino acids inhibit oxidative stress-induced necrosis and attenuate myocardial ischemia-reperfusion injury |
| Q55008053 | Knockdown of KLF11 attenuates hypoxia/reoxygenation injury via JAK2/STAT3 signaling in H9c2. |
| Q57126620 | L. Improved Heart Function and Inhibited Myocardial Apoptosis in Isolated Rat Heart Following Ischemia-Reperfusion Injury |
| Q90745602 | Lack of a Sense of Threat and Higher Emotional Lability in Patients With Chronic Microvascular Ischemia as Measured by Non-linear EEG Parameters |
| Q98895747 | Large Animal Models of Heart Failure: A Translational Bridge to Clinical Success |
| Q90512666 | Left Ventricular Unloading Before Reperfusion Promotes Functional Recovery After Acute Myocardial Infarction |
| Q91735378 | Light-emitting diode therapy protects against ventricular arrhythmias by neuro-immune modulation in myocardial ischemia and reperfusion rat model |
| Q37670940 | Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis. |
| Q91025971 | LncRNA MALAT1 knockdown alleviates oxygen-glucose deprivation and reperfusion induced cardiomyocyte apoptotic death by regulating miR-122 |
| Q92319477 | Long noncoding RNA-MEG3 contributes to myocardial ischemia-reperfusion injury through suppression of miR-7-5p expression |
| Q64084650 | Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing |
| Q55383720 | Low-Dose 4-Hydroxy-2-Nonenal (HNE) Reperfusion Therapy Displays Cardioprotective Effects in Mice After Myocardial Infarction That Are Abrogated by Genipin. |
| Q51176986 | Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H). |
| Q39340752 | MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics. |
| Q48630021 | Mapping immune cell infiltration using restricted diffusion MRI. |
| Q33800230 | Mdivi-1 induced acute changes in the angiogenic profile after ischemia-reperfusion injury in female mice |
| Q35591986 | Mechanisms Involved in Exercise-Induced Cardioprotection: A Systematic Review. |
| Q38326656 | Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations |
| Q93173172 | Melatonin elicits protective effects on OGD/R‑insulted H9c2 cells by activating PGC‑1α/Nrf2 signaling |
| Q55253083 | Melatonin-Induced Protective Effects on Cardiomyocytes Against Reperfusion Injury Partly Through Modulation of IP3R and SERCA2a Via Activation of ERK1. |
| Q89807074 | Mesenchymal Stem Cells Promote the Resolution of Cardiac Inflammation After Ischemia Reperfusion Via Enhancing Efferocytosis of Neutrophils |
| Q64275072 | Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization |
| Q92602951 | Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention |
| Q37508043 | Metformin in Diabetic Patients with Heart Failure: Safe and Effective? |
| Q59138339 | Metformin: An Old Drug with New Applications |
| Q58699159 | MiR-320 regulates cardiomyocyte apoptosis induced by ischemia-reperfusion injury by targeting AKIP1 |
| Q92036851 | MiR-484 Protects Rat Myocardial Cells from Ischemia-Reperfusion Injury by Inhibiting Caspase-3 and Caspase-9 during Apoptosis |
| Q90642848 | MicroRNA-138 attenuates myocardial ischemia reperfusion injury through inhibiting mitochondria-mediated apoptosis by targeting HIF1-α |
| Q61799147 | MicroRNA-144 attenuates cardiac ischemia/reperfusion injury by targeting FOXO1 |
| Q33702159 | MicroRNA-15a inhibition protects against hypoxia/reoxygenation-induced apoptosis of cardiomyocytes by targeting mothers against decapentaplegic homolog 7. |
| Q49474782 | MicroRNA-206 Protects against Myocardial Ischaemia-Reperfusion Injury in Rats by Targeting Gadd45β. |
| Q99630341 | MicroRNA-214-5p protects against myocardial ischemia reperfusion injury through targeting the FAS ligand |
| Q35190448 | MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7. |
| Q64242876 | MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes |
| Q55509396 | MicroRNA‑20b‑5p promotes ventricular remodeling by targeting the TGF‑β/Smad signaling pathway in a rat model of ischemia‑reperfusion injury. |
| Q60056507 | Microvesicles and Exosomes in Local and Distant Communication with the Heart |
| Q26770233 | Microvesicles and exosomes: new players in metabolic and cardiovascular disease |
| Q41472664 | Mitigation of myocardial ischemia-reperfusion injury via HIF-1α-frataxin signaling |
| Q58611546 | Mitochondria as a therapeutic target for common pathologies |
| Q90963905 | Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo |
| Q64886537 | Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation. |
| Q92733130 | Mitochondrial Quality Control: Role in Cardiac Models of Lethal Ischemia-Reperfusion Injury |
| Q90187491 | Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury |
| Q39220742 | Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection? |
| Q46368801 | Modeling oxygen requirements in ischemic cardiomyocytes. |
| Q63459835 | Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes |
| Q58561894 | Models of Ischemia-Reperfusion Injury |
| Q34999159 | Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats |
| Q34547638 | Modulation of signaling mechanisms in the heart by thioredoxin 1. |
| Q26778211 | Molecular Characterization of Reactive Oxygen Species in Myocardial Ischemia-Reperfusion Injury |
| Q89052824 | Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA |
| Q37052474 | Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction |
| Q52680128 | Molecular mechanism and therapy application of necrosis during myocardial injury. |
| Q92541680 | Molecular mechanisms underlying gallic acid effects against cardiovascular diseases: An update review |
| Q38760245 | Moving Forwards by Blocking Back-Flow: The Yin and Yang of MI Therapy |
| Q54978972 | Mst1: function and mechanism in brain and myocardial ischemia reperfusion injury. |
| Q64101459 | Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy |
| Q91594685 | Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition |
| Q97069866 | Myocardial ischaemia-reperfusion injury and cardioprotection in perspective |
| Q38827123 | NDUFA4L2 protects against ischaemia/reperfusion-induced cardiomyocyte apoptosis and mitochondrial dysfunction by inhibiting complex I. |
| Q58792489 | Na/K-ATPase Signaling and Cardiac Pre/Postconditioning with Cardiotonic Steroids |
| Q37081749 | Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation. |
| Q57116116 | Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches |
| Q26799750 | Netrin-1 as a novel therapeutic target in cardiovascular disease: to activate or inhibit? |
| Q99717148 | Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages |
| Q33587119 | Neutrophil stunning by metoprolol reduces infarct size |
| Q41097787 | Nicotinic acetylcholine receptor-mediated protection of the rat heart exposed to ischemia reperfusion. |
| Q38184206 | Nitrite reduction and cardiovascular protection |
| Q91642265 | Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection |
| Q58730374 | Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection |
| Q33812924 | Novel adjunctive treatments of myocardial infarction |
| Q42290403 | Oleuropein Protects Cardiomyocyte against Apoptosis via Activating the Reperfusion Injury Salvage Kinase Pathway In Vitro. |
| Q38177382 | Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1 |
| Q50568281 | Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats. |
| Q58557149 | Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial |
| Q38838459 | Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2. |
| Q91956212 | Overexpression of microRNA-202-3p protects against myocardial ischemia-reperfusion injury through activation of TGF-β1/Smads signaling pathway by targeting TRPM6 |
| Q88058263 | Oxidative cross-linking of proteins to DNA following ischemia-reperfusion injury |
| Q38172089 | Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage |
| Q90307761 | PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid-lowering effects |
| Q39347543 | PET measurements of myocardial blood flow post myocardial infarction: Relationship to invasive and cardiac magnetic resonance studies and potential clinical applications |
| Q59127320 | PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation |
| Q37721711 | PTPIP51 regulates mouse cardiac ischemia/reperfusion through mediating the mitochondria-SR junction |
| Q55390520 | Panax ginseng Polysaccharide Protected H9c2 Cardiomyocyte From Hypoxia/Reoxygenation Injury Through Regulating Mitochondrial Metabolism and RISK Pathway. |
| Q91891589 | Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway |
| Q26781796 | Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection |
| Q89012656 | Pathological Roles of Iron in Cardiovascular Disease |
| Q38596702 | Pathophysiology of Myocardial Infarction |
| Q57116150 | Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling |
| Q49684124 | Pericytes constrict blood vessels after myocardial ischemia |
| Q38137849 | Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury |
| Q58702398 | Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites |
| Q37736155 | Phellinus linteus Mycelium Alleviates Myocardial Ischemia-Reperfusion Injury through Autophagic Regulation |
| Q64970706 | Platelet Contributions to Myocardial Ischemia/Reperfusion Injury. |
| Q36975889 | Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass |
| Q64274965 | Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target |
| Q39343342 | Platelets, diabetes and myocardial ischemia/reperfusion injury. |
| Q92399833 | Poly (ADP-ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy |
| Q48231806 | Postconditioning with metformin attenuates apoptotic events in cardiomyoblasts associated with ischemic reperfusion injury. |
| Q47162467 | Potential of Bioactive Glasses for Cardiac and Pulmonary Tissue Engineering |
| Q64085300 | Potential role of exosomes in the pathophysiology, diagnosis, and treatment of hypoxic diseases |
| Q42348056 | Potential therapeutics for myocardial ischemia-reperfusion injury. Focus on "Induction of cardioprotection by small netrin-1-derived peptides". |
| Q64084254 | Pre-treatment with a combination of Shenmai and Danshen injection protects cardiomyocytes against hypoxia/reoxygenation- and HO-induced injury by inhibiting mitochondrial permeability transition pore opening |
| Q36850078 | Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways |
| Q104064750 | Primidone blocks RIPK1-driven cell death and inflammation |
| Q46255610 | Propofol Prevents Oxidative Stress by Decreasing the Ischemic Accumulation of Succinate in Focal Cerebral Ischemia-Reperfusion Injury |
| Q98623182 | Propofol-induced MiR-20b expression initiates endogenous cellular signal changes mitigating hypoxia/re-oxygenation-induced endothelial autophagy in vitro |
| Q91943586 | Prostacyclin Analogue-Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats |
| Q26748618 | Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy |
| Q37701229 | Prostaglandin E2 reduces swine myocardial ischemia reperfusion injury via increased endothelial nitric oxide synthase and vascular endothelial growth factor expression levels |
| Q64085447 | Protection against cardiac ischemia-reperfusion injury by hypothermia and by inhibition of succinate accumulation and oxidation is additive |
| Q48264897 | Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center |
| Q91705325 | Protective Effect Of Vasicine Against Myocardial Infarction In Rats Via Modulation Of Oxidative Stress, Inflammation, And The PI3K/Akt Pathway |
| Q64250714 | Protective Effects of Extract against Cardiac Ischemia/Reperfusion Injury in Spontaneously Hypertensive Rats |
| Q48880463 | Protective Effects of Pterostilbene Against Myocardial Ischemia/Reperfusion Injury in Rats |
| Q54280898 | Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling. |
| Q47277096 | Protective effect of celastrol on myocardial ischemia-reperfusion injury. |
| Q89341498 | Protective effect of morin on myocardial ischemia‑reperfusion injury in rats |
| Q49852588 | Protective effects of GV1001 on myocardial ischemia‑reperfusion injury. |
| Q37736291 | Protective effects of tanshinone IIA sodium sulfonate on ischemia-reperfusion-induced myocardial injury in rats |
| Q49738106 | Protective role of STVNa in myocardial ischemia reperfusion injury by inhibiting mitochondrial fission |
| Q94601282 | Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction |
| Q28256472 | Protein quality control and metabolism: bidirectional control in the heart |
| Q64935249 | Proteomics Research on the Protective Effect of Mangiferin on H9C2 Cell Injury Induced by H2O2. |
| Q50955954 | Punicalagin Pretreatment Attenuates Myocardial Ischemia-Reperfusion Injury via Activation of AMPK. |
| Q52353629 | Purinergic Regulation of Neutrophil Function. |
| Q90111757 | Quantification of intramyocardial hemorrhage volume using magnetic resonance imaging with three-dimensional T1-weighted sequence in patients with ischemia-reperfusion injury: a semi-automated image processing technique |
| Q38377369 | Quantitative cardiac phosphoproteomics profiling during ischemia-reperfusion in an immature swine model |
| Q37371205 | Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway |
| Q42703908 | ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury |
| Q49896899 | Radiolabeled Duramycin: Promising Translational Imaging of Myocardial Apoptosis. |
| Q90355066 | Real-time local oxygen measurements for high resolution cellular imaging |
| Q38648760 | Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications. |
| Q57807470 | Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target |
| Q49788549 | Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice. |
| Q64065918 | Regenerative Cardiovascular Therapies: Stem Cells and Beyond |
| Q35064243 | Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion |
| Q89753006 | Regulation of metabolism by mitochondrial enzyme acetylation in cardiac ischemia-reperfusion injury |
| Q58563445 | Relationships between circulating branched chain amino acid concentrations and risk of adverse cardiovascular events in patients with STEMI treated with PCI |
| Q38940630 | Relaxin' the Heart: A Novel Therapeutic Modality |
| Q89978268 | Remote Ischemic Preconditioning induces Cardioprotective Autophagy and Signals through the IL-6-Dependent JAK-STAT Pathway |
| Q38249023 | Remote conditioning the heart overview: translatability and mechanism |
| Q36532517 | Remote ischaemic conditioning: cardiac protection from afar. |
| Q58566940 | Remote ischemic conditioning in ST-segment elevation myocardial infarction - an update |
| Q89367256 | Reperfusing the myocardium - a damocles Sword |
| Q37714720 | Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK. |
| Q45050521 | Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism |
| Q33861937 | Restoration of autophagic flux in myocardial tissues is required for cardioprotection of sevoflurane postconditioning in rats |
| Q64269543 | Resveratrol alleviates hypoxia/reoxygenation injury‑induced mitochondrial oxidative stress in cardiomyocytes |
| Q58725811 | Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury |
| Q36194029 | Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease |
| Q33847421 | Role of angiopoietin-2 in the cardioprotective effect of fibroblast growth factor 21 on ischemia/reperfusion-induced injury in H9c2 cardiomyocytes |
| Q39249816 | Role of glycogen synthase kinase following myocardial infarction and ischemia-reperfusion. |
| Q53136063 | Roles of MicroRNA-195 in cardiomyocyte apoptosis induced by myocardial ischemia-reperfusion injury. |
| Q47098725 | Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury |
| Q38256778 | Roles of obese-insulin resistance and anti-diabetic drugs on the heart with ischemia-reperfusion injury |
| Q28076837 | SIRT3 in Cardiac Physiology and Disease |
| Q98778877 | SNHG16 accelerates the proliferation of primary cardiomyocytes by targeting miRNA-770-5p |
| Q51810981 | Safety and feasibility of local myocardial hypothermia. |
| Q36211215 | Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes |
| Q52561276 | Salvia miltiorrhizaBurge (Danshen): A golden herbal medicine in cardiovascular therapeutics. |
| Q89536625 | Sappanone A Protects Against Myocardial Ischemia Reperfusion Injury by Modulation of Nrf2 |
| Q89870664 | Sappanone A alleviates hypoxia/reoxygenation-induced cardiomyocytes injury through inhibition of mitochondrial apoptosis and activation of PI3K-Akt-Gsk-3β pathway |
| Q42068530 | Sauchinone augments cardiomyocyte viability by enhancing autophagy proteins -PI3K, ERK(1/2), AMPK and Beclin-1 during early ischemia-reperfusion injury in vitro |
| Q91643357 | Sevoflurane postconditioning alleviates hypoxia-reoxygenation injury of cardiomyocytes by promoting mitochondrial autophagy through the HIF-1/BNIP3 signaling pathway |
| Q92136696 | Significant reduction of ischemia-reperfusion cell death in mouse myocardial infarcts using the immediate-acting PrC-210 ROS-scavenger |
| Q55411204 | Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury. |
| Q89176614 | Size-Dependent Ability of Liposomes to Accumulate in the Ischemic Myocardium and Protect the Heart |
| Q91942070 | Slit2 Protects Hearts Against Ischemia-Reperfusion Injury by Inhibiting Inflammatory Responses and Maintaining Myofilament Contractile Properties |
| Q47614023 | Sodium Thiosulfate Preconditioning Ameliorates Ischemia/Reperfusion Injury in Rat Hearts Via Reduction of Oxidative Stress and Apoptosis. |
| Q37648367 | Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway |
| Q64080446 | Stromal cell-derived factor-1α signals via the endothelium to protect the heart against ischaemia-reperfusion injury |
| Q38202410 | Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. |
| Q30851880 | Structure-redox-relaxivity relationships for redox responsive manganese-based magnetic resonance imaging probes |
| Q39901435 | Succinate Accumulation and Ischemia-Reperfusion Injury: Of Mice but Not Men, a Study in Renal Ischemia-Reperfusion. |
| Q46618771 | Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition. |
| Q34527213 | Succinate metabolism: a new therapeutic target for myocardial reperfusion injury. |
| Q38717638 | Surface-modified particles loaded with CaMKII inhibitor protect cardiac cells against mitochondrial injury. |
| Q87034029 | Systemic toll-like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction |
| Q92305799 | Systems Network Genomic Analysis Reveals Cardioprotective Effect of MURC/Cavin-4 Deletion Against Ischemia/Reperfusion Injury |
| Q36040487 | T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. |
| Q90650189 | TAT-dextran-mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes |
| Q38826190 | TGF-β improves myocardial function and prevents apoptosis induced by anoxia-reoxygenation, through the reduction of endoplasmic reticulum stress |
| Q55342846 | TGF-β/Smad3 pathway enhances the cardio-protection of S1R/SIPR1 in in vitro ischemia-reperfusion myocardial cell model. |
| Q38383096 | TNNI3K in cardiovascular disease and prospects for therapy. |
| Q35155010 | Targeted NGF siRNA delivery attenuates sympathetic nerve sprouting and deteriorates cardiac dysfunction in rats with myocardial infarction. |
| Q90862847 | Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles |
| Q92823429 | Targeting Mitochondrial Fission Using Mdivi-1 in A Clinically Relevant Large Animal Model of Acute Myocardial Infarction: A Pilot Study |
| Q46243656 | Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases. |
| Q39039959 | Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling |
| Q38595544 | Targeting danger-associated molecular patterns after myocardial infarction |
| Q36094149 | Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers |
| Q38206842 | Targeting mitochondria for cardioprotection: examining the benefit for patients. |
| Q37738596 | Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. |
| Q99629091 | Targeting succinate dehydrogenase with malonate ester prodrugs decreases renal ischemia reperfusion injury |
| Q26744359 | Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death |
| Q91808620 | The Association of Ascorbic Acid, Deferoxamine and N-Acetylcysteine Improves Cardiac Fibroblast Viability and Cellular Function Associated with Tissue Repair Damaged by Simulated Ischemia/Reperfusion |
| Q57175391 | The Effects of Potassium Cyanide on the Functional Recovery of Isolated Rat Hearts after Ischemia and Reperfusion: The Role of Oxidative Stress |
| Q64230739 | The Guizhi Gancao Decoction Attenuates Myocardial Ischemia-Reperfusion Injury by Suppressing Inflammation and Cardiomyocyte Apoptosis |
| Q89736120 | The Pomace Extract Taurisolo Protects Rat Brain From Ischemia-Reperfusion Injury |
| Q99615238 | The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction |
| Q42368418 | The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation |
| Q90232213 | The Role of Lipopolysaccharide-Induced Extracellular Vesicles in Cardiac Cell Death |
| Q90568414 | The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury |
| Q26747310 | The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies |
| Q51395640 | The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways. |
| Q55316827 | The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury. |
| Q38705817 | The challenges and impact of microvascular injury in ST-elevation myocardial infarction |
| Q64097624 | The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury |
| Q36342106 | The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases |
| Q91846247 | The lymphocyte adapter protein: A negative regulator of myocardial ischemia/reperfusion injury |
| Q38274962 | The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury. |
| Q38245433 | The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury. |
| Q33823814 | The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats |
| Q90092681 | The optimal model of reperfusion injury in vitro using H9c2 transformed cardiac myoblasts |
| Q37366133 | The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. |
| Q38775962 | The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart |
| Q34486554 | The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model |
| Q37139158 | The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair |
| Q47288476 | The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction |
| Q52730972 | The unfolded protein response in ischemic heart disease. |
| Q49942720 | Therapeutic Effects of Ischemic-Preconditioned Exosomes in Cardiovascular Diseases |
| Q90344406 | Therapeutic Hypothermia Protects Against Heat Stroke-Induced Arterial Hypotension via Promoting Left Ventricular Performance in Rats |
| Q54988971 | Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury. |
| Q38866803 | Therapeutic targeting of autophagy in myocardial infarction and heart failure. |
| Q30589568 | Three-dimensional myocardial scarring along myofibers after coronary ischemia-reperfusion revealed by computerized images of histological assays |
| Q91530211 | Thrombo-inflammation in acute ischaemic stroke - implications for treatment |
| Q28541982 | Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension |
| Q37393468 | Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury |
| Q92711721 | Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms |
| Q58697406 | Trichosanthis Pericarpium Aqueous Extract Protects H9c2 Cardiomyocytes from Hypoxia/Reoxygenation Injury by Regulating PI3K/Akt/NO Pathway |
| Q26864088 | Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease |
| Q47348883 | Umbelliferone Alleviates Myocardial Ischemia: the Role of Inflammation and Apoptosis |
| Q37577025 | Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization |
| Q36395058 | Unfolded protein response plays a critical role in heart damage after myocardial ischemia/reperfusion in rats |
| Q92840305 | Upregulation of miR-202-5p promotes cell apoptosis and suppresses cell viability of hypoxia-induced myocardial H9c2 cells by targeting SOX6 to inhibit the activation of the PI3K/AKT/FOXO3a pathway |
| Q60953149 | Upregulation of miR-335 ameliorates myocardial ischemia reperfusion injury via targeting hypoxia inducible factor 1-alpha subunit inhibitor |
| Q36188738 | Urocortin Treatment Improves Acute Hemodynamic Instability and Reduces Myocardial Damage in Post-Cardiac Arrest Myocardial Dysfunction. |
| Q36956766 | Variant Aldehyde Dehydrogenase 2 (ALDH2*2) Is a Risk Factor for Coronary Spasm and ST-Segment Elevation Myocardial Infarction |
| Q52677026 | Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise. |
| Q89182402 | Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning |
| Q38803474 | Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis |
| Q40348381 | Virus-Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes |
| Q37397458 | Water-soluble acacetin prodrug confers significant cardioprotection against ischemia/reperfusion injury |
| Q90676339 | circDLPAG4/HECTD1 mediates ischaemia/reperfusion injury in endothelial cells via ER stress |
| Q64226437 | extract-761 protects myocardium by regulating Akt/Nrf2 signal pathway |
| Q91712167 | lncRNA H19 Alleviated Myocardial I/RI via Suppressing miR-877-3p/Bcl-2-Mediated Mitochondrial Apoptosis |
| Q64281625 | l‐α‐Lysophosphatidylinositol ( LPI ) aggravates myocardial ischemia/reperfusion injury via a GPR 55/ ROCK ‐dependent pathway |
| Q93024751 | miR-26a-5p protects against myocardial ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT signaling pathway |
| Q36661786 | miR-429 regulates the transition between Hypoxia-Inducible Factor (HIF)1A and HIF3A expression in human endothelial cells |
| Q92545603 | miR‑155 inhibition represents a potential valuable regulator in mitigating myocardial hypoxia/reoxygenation injury through targeting BAG5 and MAPK/JNK signaling |
| Q90276033 | mtDNA Activates cGAS Signaling and Suppresses the YAP-Mediated Endothelial Cell Proliferation Program to Promote Inflammatory Injury |
| Q47671228 | β-arrestin 2 mediates cardiac ischemia-reperfusion injury via inhibiting GPCR-independent cell survival signalling |
Search more.